HAYWARD, Calif. & FORT DODGE, Iowa--(BUSINESS WIRE)--Lygos, a sustainable specialty chemical company, announced today the signing of an MOU agreement with global fermentation and biotechnology leader, ...
GlobalData on MSN
Massive Bio partners with OpenAI to broaden clinical trial access
Through working with OpenAI, Massive Bio converts complex clinical trial criteria into machine-readable formats.
Oncology-focused digital health company Flatiron Health announced it entered into a strategic partnership with Massive Bio, a company that helps cancer patients find and enroll in clinical trials.
Cellino, a biotechnology firm working on autonomous biomanufacturing for personalized regenerative medicines, has signed a strategic collaboration with Karis Bio, a South Korean cell therapy company, ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, ...
MINNEAPOLIS, Jan. 30, 2026 /PRNewswire/ -- Pivot Bio, one of the world's leading innovative agtech companies, today announced it has been named Grand Farm Partner of the Year as part of Emerging ...
Adagene to provide proprietary antibody to ConjugateBio for development as novel bispecific ADCs About AdageneAdagene Inc. (Nasdaq: ADAG) is a platform-driven, clinical-stage biotechnology company ...
PHILADELPHIA, PA & BOSTON, MA — Tolerance Bio and ZipCode Bio have entered a strategic research and development collaboration to create novel delivery methods for thymus-targeted therapeutics, aiming ...
Overture Life, the global leader in automated IVF, and Spectrun Bio, a specialist in life sciences commercialization and clinical support across Brazil, today announced a strategic partnership to ...
Collaboration with intent to validate Cellares’ Cell Shuttle platform for manufacturing of CABA-201, Cabaletta Bio’s fully human CD19-CAR T product candidate, which is being evaluated in parallel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results